| 1. |
2024
Delila Liling,Nebie Ouada,Le Nhi Thao Ngoc,Timmerman Kelly,Lee Deng Yao,Wu Yu Wen,Chou Ming Li,Buée Luc,Chou Szu Yi,Blum David,Devos David,Burnouf Thierry,Delila Liling,Nebie Ouada,Le Nhi Thao Ngoc,Timmerman Kelly,Lee Deng Yao,Wu Yu Wen,Chou Ming Li,Buée Luc,Chou Szu Yi,Blum David,Devos David,Burnouf Thierry.
Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson{\textquoterights disease models
. Journal of Biomedical Science
.2024
;(31)
|
|
| 2. |
2024
Le Nhi Thao Ngoc,Han Chia Li,Delila Liling,Nebie Ouada,Chien Hsin Tung,Wu Yu Wen,Buée Luc,Blum David,Burnouf Thierry,Le Nhi Thao Ngoc,Han Chia Li,Delila Liling,Nebie Ouada,Chien Hsin Tung,Wu Yu Wen,Buée Luc,Blum David,Burnouf Thierry.
Proteomics of human platelet lysates and insight from animal studies on platelet protein diffusion to hippocampus upon intranasal administration
. APL Bioengineering
.2024
;(8)
|
|
| 3. |
2024
Burnouf Thierry,Epstein Jay,Faber Jean Claude,Smid W. Martin,Burnouf Thierry,Epstein Jay,Faber Jean Claude,Smid W. Martin.
Response to comments from the International Patient Organization for Primary Immunodeficiencies on {\textquoteleftStepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries{\textquoteright
. Vox Sanguinis
.2024
;(119):1023-1024
|
|
| 4. |
2024
Bhatnagar Sonu,Burnouf Thierry,Prevot Johan,Faber Jean Claude,Büechel René,Maryuningsih Yuyun Siti,Khanh Bach Quoc,Mai Nguyen Thi,Nakanishi Hideo,Kataoka Masako,Bhatnagar Sonu,Burnouf Thierry,Prevot Johan,Faber Jean Claude,Büechel René,Maryuningsih Yuyun Siti,Khanh Bach Quoc,Mai Nguyen Thi,Nakanishi Hideo,Kataoka Masako.
Navigating the Asia-Pacific region plasma therapies landscape: Insights from the 2023 Asia-Pacific Plasma Leaders' Network meetings
. Vox Sanguinis
.2024
|
|
| 5. |
2024
Livkisa Dora,Chang Tzu Hsin,Burnouf Thierry,Czosseck Andreas,Le Nhi Thao Ngoc,Shamrin Gleb,Yeh Wei Ting,Kamimura Masao,Lundy David J.,Livkisa Dora,Chang Tzu Hsin,Burnouf Thierry,Czosseck Andreas,Le Nhi Thao Ngoc,Shamrin Gleb,Yeh Wei Ting,Kamimura Masao,Lundy David J..
Extracellular vesicles purified from serum-converted human platelet lysates offer strong protection after cardiac ischaemia/reperfusion injury
. Biomaterials
.2024
;(306)
|
|
| 6. |
2024
Epstein J,Maryuningsih Y,Faber JC,Martin WM,Burnouf T.
Inclusion of cryoprecipitate, pathogen-reduced, in the who model lists of essential medicines for adults and children: a call for action.
. Blood Transfusion
.2024
|
|
| 7. |
2024
Yeh Wei Ting,Yu Ezrin Yi Ling,Lu Ya Hsuan,Livkisa Dora,Burnouf Thierry,Lundy David J.,Yeh Wei Ting,Yu Ezrin Yi Ling,Lu Ya Hsuan,Livkisa Dora,Burnouf Thierry,Lundy David J..
Bioprocessing of human platelet concentrates to generate lysates and extracellular vesicles for therapeutic applications
. MethodsX
.2024
;(13)
|
|
| 8. |
2024
Ho Man Hau,Tsai Yih Jeng,Chen Chia Yen,Yang Anastasia,Burnouf Thierry,Wang Yun,Chiang Yung Hsiao,Hoffer Barry J.,Chou Szu Yi,Ho Man Hau,Tsai Yih Jeng,Chen Chia Yen,Yang Anastasia,Burnouf Thierry,Wang Yun,Chiang Yung Hsiao,Hoffer Barry J.,Chou Szu Yi.
CCL5 is essential for axonogenesis and neuronal restoration after brain injury
. Journal of Biomedical Science
.2024
;(31)
|
|
| 9. |
2024
Back F,Barras A,Nyam-Erdene A, Yang JC,Melinte S,Rumipamba J, Burnouf T, Boukherroub R, Szunerits S, Chuang EY.
Platelet Extracellular Vesicles Loaded Gelatine Hydrogels for Wound Care.
. Advanced Healthcare Materials
.2024
|
|
| 10. |
2024
So-Osman C,Burnouf T,Al-Riyami A,Bloch EM,Estcourt L,Goel R, Tiberghien P, Vermeulen M, Wendel S, Wood EM.
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness.
. Frontiers in Immunology
.2024
|
|
| 11. |
2024
Burnouf T,Epstein J,Faber JC,WM Smid.
Stepwise options for preparing therapeutic Plasma proteins from domestic plasma in low- and middle-income countries
. Vox Sanguinis
.2024
|
|
| 12. |
2024
Lin Jia Cheng,Kaswan Kuldeep,Chatterjee Subhodeep,Wu Yu Wen,Kumar Sharma Manish,Ranjan Ashok,Roy Barman Snigdha,Lin Yu Zih,Burnouf Thierry,Boireau Wilfrid,Lu Ming Yen,Tu Yong Kwang,Su I. Chang,Wu Ping Hsiu,Lin Zong Hong,Fan Yu Jui,Lin Jia Cheng,Kaswan Kuldeep,Chatterjee Subhodeep,Wu Yu Wen,Kumar Sharma Manish,Ranjan Ashok,Roy Barman Snigdha,Lin Yu Zih,Burnouf Thierry,Boireau Wilfrid,Lu Ming Yen,Tu Yong Kwang,Su I. Chang,Wu Ping Hsiu,Lin Zong Hong,Fan Yu Jui.
CuO NWs boosted triboelectric microfluidic nanosensor functionalized by collagen-protein interactions for real-time platelet count monitoring
. Chemical Engineering Journal
.2024
;(490)
|
|
| 13. |
2024
Towards personalized and rational use of immunoglobulins amid expanding indications and shortages
. Transfusion and Apheresis Science
.2024
;(63)
|
|
| 14. |
2023
Hao Ping Chien,Burnouf Thierry,Chiang Chih Wei,Jheng Pei Ru,Szunerits Sabine,Yang Jen Chang,Chuang Er Yuan,Hao Ping Chien,Burnouf Thierry,Chiang Chih Wei,Jheng Pei Ru,Szunerits Sabine,Yang Jen Chang,Chuang Er Yuan.
Enhanced diabetic wound healing using platelet-derived extracellular vesicles and reduced graphene oxide in polymer-coordinated hydrogels
. Journal of Nanobiotechnology
.2023
;(21)
|
|
| 15. |
2023
Burnouf T,Chou ML,Lundy DJ,Chuang EY,Tseng CL,Goubran H.
Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery
. Journal of Biomedical Science
.2023
;(30):1-34
|
|
| 16. |
2023
Khalil A,Barras A,Boukherroub R,Tseng CL,Devos D,Burnouf T, Neuhaus W, Szunerits S.
Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases
. Nanoscale Horizons
.2023
|
|
| 17. |
2023
Wu YH,Chao HS,Chiang CL,Luo YH,Chiu CH,Yen SH, Liu CY, Chiou JF, Burnouf T, Chen YJ, Wang PY, Chao TY, Hsu SM, Lu LS.
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids
. Thorac Cancer
.2023
;(14):2591-2600
|
|
| 18. |
2023
Kumar P,Pandith A,Tseng CT,Burnouf T.
Recent Developments in Mitochondrial G-Quadruplex Recognising Fluorescent Probes: A Review
. Journal of Photochemistry & Photobiology, C: Photochemistry Reviews
.2023
;(56):1-39
|
|
| 19. |
2023
Wu YW,Lee DY,Lu YL,Delila L,Nebie O,Barro L, Changou CA, Lu LS, Goubran H, Burnouf T.
Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: Preparation and in vitro characterization
. Platelets
.2023
;(34):1-12
|
|
| 20. |
2023
Chou ML,Babamale OA,Walker T,Cognasse F,Blum D,Burnouf T.
Blood-brain crosstalk: the roles of neutrophils, platelets, and neutrophil extracellular traps in neuropathologies
. Trends in Neurosciences
.2023
;(46):764-779
|
|
| 21. |
2023
McIntosh D,Burnouf T,Karbiener M,Farcet MR,Kreil TR.
Prevention and treatment of COVID-19 by mono- and poly-clonal antibodies
. Blood Transfusion
.2023
;(21):375-377
|
|
| 22. |
2023
Liu YW,Burnouf T,Chang CY,Chen SH,Chen YJ,Chen YH, Ho WL, Liao YM, Lin PC, Liu YL, James S Miser, Wang JL, Wang PY, Wang SC, Wong TT, Wu SP, Wu YH, Chiou JF, Lu LS .
Treatment response prediction with circulating tumor cell-derived organoids for soft tissue sarcoma
. Journal of Clinical Oncology
.2023
;(41):e23521-e23521
|
|
| 23. |
2023
Gabriel C,Marks DC,Henschler R,Schallmoser K,Burnouf T,Koh MBC.
Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies
. Vox Sanguinis
.2023
;(118):301-309
|
|
| 24. |
2023
Shouman M,Goubran H,Seghatchian J,Burnouf T.
Hematological toxicities of immune checkpoint inhibitors and the impact of blood transfusion and its microbiome on therapeutic efficacy and recipient's safety and survival outcome:A systematic narrative appraisal of where we are now!
. Transfusion & Apheresis Science
.2023
;(62):1-6
|
|
| 25. |
2023
Chen YT,Liu CH,Pan WY,Jheng PR,Hsieh YSY,Burnouf T, Fan YJ, Chiang CC, Chen TY, Chuang EY.
Biomimetic Platelet Nanomotors for Site-Specific Thrombolysis and Ischemic Injury Alleviation
. ACS Applied Materials & Interfaces
.2023
;(15):32967-32983
|
|
| 26. |
2022
Al-Riyami AZ,Burnouf T,Wood EM,Devine VD,Oreh A,Apelseth TO, et al.
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic
. Vox Sanguinis
.2022
;(117):822-830
|
|
| 27. |
2022
Burnouf T,Epstein J,Faber JC,Smid M.
Stepwise access to safe plasma proteins in resource-constrained countries: Local production and pathways to fractionation-Report of an International Society of Blood Transfusion Workshop
. Vox Sanguinis
.2022
;(117):789-795
|
|
| 28. |
2022
Focosi D,Franchini M,Pirofski LA,Burnouf T,Paneth N,Joyner MJ, Casadevall A.
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
. Clinical Microbiology Reviews
.2022
;(35):1-29
|
|
| 29. |
2022
Burnouf T,Jheng PR,Chen YH,Rethi L,Rethi L,Lu LS, Ho YC, Chuang EY.
Near-infrared-driven photoablation of lung cancer tumors utilizing biomimetic platelet-polyethyleneimine-polypyrrole drug-free nanoparticles
. Materials & Design
.2022
;(215):1-12
|
|
| 30. |
2022
Hartmann J,Bloch EM,Burnouf T.
Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics
. Transfusion
.2022
;(62):681-684
|
|
| 31. |
2022
Burnouf T,Goubran HA.
Regenerative effect of expired platelet concentrates in human therapy: An update
. Transfusion & Apheresis Science
.2022
;(61):1-3
|
|
| 32. |
2022
Wu Y-H,Hung Y-P,Chiu N-C,Lee R-C,Li C-P,Chao Y, Shyr Y-M, Wang S-E, Chen S-C, Lin S-H, Chen Y-H, Kang Y-M, Hsu S-M, Yen S-H, Wu J-Y, Lee K-D, Tseng H-E, Tsai J-R, Tang J-H, Chiou J-F, Burnouf T, Chen Y-J, Wang P-Y, Lu L-S*.
Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma
. European Journal of Cancer
.2022
;(166):208-218
|
|
| 33. |
2022
Belem WF,Liu C-H,Hu Y-T,Burnouf T,Lin L-T.
Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2)
. Viruses-Basel
.2022
;(14)
|
|
| 34. |
2022
Holmberg JA,Henry SM,Burnouf T,Devine D,Marschner S,et al..
National Blood Foundation 2021 Research and Development summit: Discovery, innovation, and challenges in advancing blood and biotherapies
. Transfusion
.2022
|
|
| 35. |
2022
Goubran H,Stakiw J,Seghatchian J,Ragab G,Burnouf T.
SARS-CoV-2 and cancer: the intriguing and informative cross-talk
. Transfusion & Apheresis Science
.2022
;(61):1-4
|
|
| 36. |
2022
Goubran H,Seghatchian J,Sabry W,Ragab G,Burnouf T.
Platelet and extracellular vesicles in COVID-19 infection and its vaccines
. Transfusion & Apheresis Science
.2022
;(61)
|
|
| 37. |
2022
Burnouf T,Gathof B,Bloch EM,Bazin R,Angelis VD,et al.
Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
. Transfusion Medicine Reviews
.2022
;(36):125-132
|
|
| 38. |
2022
Burnouf T,Epstein J,Faber JC,Tayou Tagny C,Somuah D,Smid WM.
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshop
. Biologicals
.2022
;(79):27-30
|
|
| 39. |
2022
Widyaningrum R,Wu YW,Delila L,Lee DY,Wang TJ,Burnouf T.
In vitro evaluation of platelet extracellular vesicles (PEVs) for corneal endothelial regeneration
. Platelets
.2022
;(33):1237-1250
|
|
| 40. |
2022
Burnouf T,Walker T.
The multifaceted role of platelets in mediating brain function
. Blood
.2022
;(140):815-827
|
|
| 41. |
2022
Nebie O,Buée L,Blum D,Burnouf T.
Can the administration of platelet lysates to the brain help treat neurological disorders?
. Cellular & Molecular Life Sciences
.2022
;(79)
|
|
| 42. |
2022
Delila L,Nebie O,Le N-T-N,Barro L,Chou M-L,Wu Y-W, Watanabe N, Takahara M, Buée L, Blum D, Devos D, Burnouf T.
Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury models
. Bioengineering & Translational Medicine
.2022
;(8):1-15
|
|
| 43. |
2022
Gouel F,Timmerman K,Gosset P,Raoul C,Dutheil M,Jonneaux A, Garçon G, Moreau C, Danel-Brunaud V, Duce J, Burnouf T, Devedjian J-C, Devos D.
Whole and fractionated human platelet lysate biomaterials-based biotherapy induces strong neuroprotection in experimental models of amyotrophic lateral sclerosis.
. Biomaterials
.2022
;(280)
|
|
| 44. |
2021
Nyam-Erdene A,Nebie O,Delila L,Buée L,Devos D,Chou S-Y, Blum D, Burnouf T.
Characterization and Chromatographic Isolation of Platelet Extracellular Vesicles from Human Platelet Lysates for Applications in Neuroregenerative Medicine
. ACS Biomaterials Science & Engineering
.2021
;(7):5823-5835
|
|
| 45. |
2021
Widyaningrum R,Burnouf T,Nebie O,Delila L,Wang TJ.
A purified human platelet pellet lysate rich in neurotrophic factors and antioxidants repairs and protects corneal endothelial cells from oxidative stress
. Biomedicine & Pharmacotherapy
.2021
;(142)
|
|
| 46. |
2021
Lin KC,Ting LL,Chang CL,Lu LS,Lee HL,Hsu FC, Chiou JF, Wang PY, Burnouf T, Ho DC, Yang KC, Chen CY, Chen CH, Wu CZ, Chen YJ .
Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer
. Cancers (Basel)
.2021
;(13)
|
|
| 47. |
2021
Focosi D,Franchini M,Pirofski L-A,Burnouf T,Paneth N,J. Joyner M, Casadevall A.
COVID-19 convalescent plasma and randomized clinical trials: explaining conflicting outcomes and finding signals of efficacy
. MedRxiv
.2021
|
|
| 48. |
2021
Widyaningrum R,Burnouf T,Nebie O,Delila L,Wang TJ.
A purified human platelet pellet lysate rich in neurotrophic factors and antioxidants repairs and protects corneal endothelial cells from oxidative stress
. Biomedicine & Pharmacotherapy
.2021
;(142):1-15
|
|
| 49. |
2021
Nebie Ouada,Barro Lassina,Wu Yu-Wen,Knutson Folke,Buee Luc,Devos David, Peng Chih-Wei, Blum David, Burnouf Thierry.
Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro.
. Platelets
.2021
;(32):226-237
|
|
| 50. |
2021
Johnson J,Wu Y-W,Blyth C,Lichtfuss G,Goubran H,Burnouf T.
Prospective Therapeutic Applications of Platelet Extracellular Vesicles.
. Trends in Biotechnology
.2021
;(39):598-612
|
|
| 51. |
2021
Liu Cheng-Sheng,Tsai Jia-Ruey,Kao Yi-Tzu,Lu Long-Sheng,Chen Yin-Ju,Burnouf Thierry, Wang Peng-Yuan, Chiou Jeng-Fong, Ting Lai-Lei.
Chemoradiotherapy for Inoperable Carotid Body Leiomyosarcoma: A Case Report and Review of Literature.
. Frontiers in Oncology
.2021
;(10)
|
|
| 52. |
2021
Wendel Silvano,Land Kevin,Devine Dana V.,Daly James,Bazin Renee,Tiberghien Pierre, Lee Cheuk-Kwong, Arora Satyam, Patidar Gopal K., Khillan Kamini, Smid Willem Martin, Vrielink Hans, Oreh Adaeze, Al-Riyami Arwa Z., Hindawi Salwa, Vermeulen Marion, Louw Vernon, Burnouf Thierry, Bloch Evan M., Goel Ruchika, Townsend Mary, So-Osman Cynthia.
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic
. Vox Sanguinis
.2021
;(116):872-879
|
|
| 53. |
2021
Daniele Focosi,Massimo Franchini,Liise-anne Pirofski,Thierry Burnouf,DeLisa Fairweather,Michael J. Joyner, Arturo Casadevall.
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
. Viruses-Basel
.2021
;(13):1594-1594
|
|
| 54. |
2021
Chan Fu-Erh,Syu Huei-Min,(Wang Te-Yi,Tang Zheng-Ting,Huang Chih-Ning,Lee Jyh-Fu, Burnouf Thierry, Hu Shang-Hsiu, Chen Po-Chun, Huang Wei-Chen.
Iridium Oxide Nanoparticle–Protein Corona Neural Interfaces with Enhanced Electroactivity and Bioactivity Enable Electrically Manipulatable Physical and Chemical Neuronal Activation
. Advanced Materials Interfaces
.2021
;(8)
|
|
| 55. |
2021
Lassina Barro,Liling Delila,Ouada Nebie,Yu-Wen Wu ,Folke Knutson,Naoto Watanabe, Masayasu Takahara, Thierry Burnouf.
Removal of minute virus of mice-mock virus particles by nanofiltration of culture growth medium supplemented with 10% human platelet lysate
. Cytotherapy
.2021
;(5):902-907
|
|
| 56. |
2021
Josephine H Cheng,Yu-Wen Wu ,Chen-Yun Wang ,Sharon S Wu , Cheum L Hong,Karen W Chan, Leo X Liao, Xisheng Cao, Bin Wang, Thierry Burnouf.
Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity
. Blood Transfusion (Italy)
.2021
|
|
| 57. |
2021
Arwa Z Al-Riyami ,Thierry Burnouf,Mark Yazer,Darrell Triulzi,Levent Tufan Kumaş,Levent Sağdur, Nil Banu Pelit, Renée Bazin,... Nancy Dunbar, ISBT Convalescent Plasma Group.
International Forum on the collection and use of COVID-19 convalescent plasma: protocols, challenges and lessons learned: Summary
. Vox Sanguinis
.2021
|
|
| 58. |
2021
Arwa Z Al-Riyami,Thierry Burnouf,Mark Yazer,Darrell Triulzi,Levent Tufan Kumaş,Levent Sağdur, Nil Banu Pelit,...Nancy Dunbar.
International Forum on the collection and use of COVID-19 convalescent plasma: Responses
. Vox Sanguinis
.2021
|
|
| 59. |
2021
Nebie O,Carvalho K,Barro L,Delila L,Faivre E,Renn TY, Chou ML, Wu YW, Niem-Redene A, Chou SY, Buée L, Hu CH, Peng CW, Devos D, Blum D, Burnouf T.
Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment
. Brain
.2021
|
|
| 60. |
2021
Delila L,Wu Y-W,Nebie O,Widyaningrum R,Chou M-L,Devos D, Burnouf T.
Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses
. Platelets
.2021
;(32(2)):259-272
|
|
| 61. |
2020
Lee H-L,Chiou J-F,Lu L-S,Shen C-N,Hsu H-L,Ting L-L, Wang P-W, Burnouf T, Chen Y-J.
In vitro expansion and drug sensitivity profiling of circulating tumor cells from patients with extensive-stage small cell lung cancer
. Cancers
.2020
|
|
| 62. |
2020
Jancy Johnson,Yu-Wen Wu,Chantelle Blyth,Gregor Lichtfuss,Hadi Goubran,Thierry Burnouf.
Prospective Therapeutic Applications of Platelet Extracellular Vesicles
. Trends in Biotechnology
.2020
|
|
| 63. |
2020
Epstein J,Smid MW,Wendel S,Somuah D,Burnouf T.
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infections
. Npj Vaccines
.2020
;(5)
|
|
| 64. |
2020
Barro L,Burnouf P-A,Chou M-L,Nebie O,Wu Y-W,Chen M-S, Radosevic M, Knutson F, Burnouf T.
Human platelet lysates for human cell propagation
. Platelets
.2020
|
|
| 65. |
2020
Schallmoser K, Henschler R,Gabriel C, Koh MBC,Burnouf T*.
Production and quality Requirements of human platelet lysate: A Position Statement from the working party on cellular therapies of the International Society of Blood Transfusion
. Trends in Biotechnology
.2020
;(38):13-23
|
|
| 66. |
2020
Wu YW,Huang CC,Changou CA,Lu LS,Goubran H,Burnouf T.
Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
. Journal Biomedical Science
.2020
;(27):1-16
|
|
| 67. |
2020
Smid WM,Burnouf T,Epstein J,Kamel H ,Sibinga CS,Somuah D,Stramer SL, Wendel S.
Points to consider in the preparation and transfusion of COVID-19 convalescent plasma in low– and middle– income countries.
. Africa Sanguine
.2020
|
|
| 68. |
2020
Epstein J,Smid M,Wendel S,Somuah D,Burnouf T*.
Use of COVID‐19 convalescent plasma in low‐ and middle‐income countries: a call for ethical principles and the assurance of quality and safety
. Vox Sanguinis
.2020
|
|
| 69. |
2020
Barro L,Nebie O,Chen M-S,Wu YW,Koh MBC,Knutson F, Watanabe N, Takahara M, Burnouf T.
Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells.
. Cytotherapy
.2020
;(22):458-472
|
|
| 70. |
2020
Bloch EM,Goel R,Wendel S,Burnouf T,Al-Riyami AZ,DeAngelis V, Dumont LJ, Land K, Lee CK, Oreh A, Patidar G, Spitalnik SL, Hindawi S, Van den Berg K, Tiberghien P, Vrielink, H, Young P, Devine D, So-Osman C., and the ISBT Convalescent Plasma Working Group.
Guidance for the Procurement of COVID‐19 Convalescent Plasma: Differences between High and Low‐Middle Income Countries.
. Vox Sanguinis
.2020
|
|
| 71. |
2020
Agrahari V,Agrahari V,Chou ML,Chew CH,Noll J, Burnouf T*.
Intelligent Micro-/Nanorobots as Drug and Cell Carrier Devices for Biomedical Therapeutic Advancement: Promising Development Opportunities and Translational Challenges
. Biomaterials
.2020
|
|
| 72. |
2020
Jay Epstein,Thierry Burnouf.
Points to consider in the preparation and transfusion of COVID-19 convalescent plasma
. Vox Sanguinis
.2020
;(115):485-487
|
|
| 73. |
2020
Epstein, Jay,Burnouf, Thierry.
Points to consider in the preparation and transfusion of COVID-19 convalescent plasma.
. Vox Sanguinis
.2020
;(115):485-487
|
|
| 74. |
2020
Sung TC,Li HF,Higuchi A,Kumar S,Lin QD,Wu YW, Burnouf T, Nasu M, Umezawa A, Lee KF, Wang HC, Chang Y, Hsu ST.
Effect of cell culture biomaterials for completely xeno-free generation of human induced pluripotent stem cells.
. Biomaterials
.2020
;(230)
|
|
| 75. |
2020
Burnouf T*,Epstein J,Faber JC.
Recovered plasma for fractionation: call for quality standards to end wastage
. Vox Sanguinis
.2020
;(115):213-214
|
|
| 76. |
2020
Sabry W,Elemary M,Burnouf T,Seghatchian J,Goubran H.
Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy
. Transfusion and Apheresis Science
.2020
;(59)
|
|
| 77. |
2020
Smid WM,Burnouf T,Epstein J,Kamel H,Sibinga CS,Somuah D,Stramer SL, Wendel S.
Eléments à prendre en compte dans la preparation et la transfusion du plasma de personnes guéries du COVID-19 dans les pays à faibles ou moyens revenus.
. Africa Sanguine
.2020
|
|
| 78. |
2019
Ming-Sheng Chen,Tsung-Jen Wang,Hsiu-Chen Lin,Thierry Burnouf.
Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells
. New Biotechnology
.2019
|
|
| 79. |
2019
Vivek Agrahari,Vibhuti Agrahari,Pierre-Alain Burnouf,Chew Chew,Thierry Burnouf.
Extracellular microvesicles as new industrial therapeutic frontiers
. Trends in Biotechnology
.2019
|
|
| 80. |
2019
Inouye M,Burnouf T.
The role of nanofiltration in the pathogen safety of biologicals: an update.
. Current nanoscience
.2019
|
|
| 81. |
2019
Henschler R,Gabriel C,Schallmoser K,Burnouf T,Koh M.
Human Platelet Lysate: Current Standards and Future Developments.
. Tranfusion
.2019
|
|
| 82. |
2019
Obeid S,Sung PS,Le Roy B,Chou ML,Hsieh SL,Caille CE, Burnouf T, Boireau W.
NanoBioAnalytical characterization of extracellular vesicles in 75-nm nanofiltered human plasma for transfusion: A tool to improve transfusion safety
. Nanomedicine
.2019
;(20)
|
|
| 83. |
2019
Barro L,Su YT,Nebie O,Wu YW,Huang YH,Mickey BC Koh ,Knutson F, Burnouf T.
A double-virally-inactivated (Intercept–solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells
. Transfusion
.2019
|
|
| 84. |
2019
Hadi Goubran,Mariam Goubran,Jerard Seghatchian,Thierry Burnouf.
New monoclonal/bi-specific antibodies: Reshaping transfusion medicine beyond replacement
. Transfusion and Apheresis Science
.2019
;(58):208-211
|
|
| 85. |
2019
Thierry Burnouf,Jean-Claude Faber,Mirjana Radosevic, Hadi Goubran, Jerard Seghatchian.
Plasma fractionation in countries with limited infrastructure and low-/medium income: how to move forward?
. Transfusion and Apheresis Science
.2019
|
|
| 86. |
2019
Agrahari V,Burnouf PA,Burnouf T,Agrahari V.
Nanoformulation properties, characterization, and behavior in complex biological matrices: challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential.
. Advanced Drug Delivery Reviews
.2019
|
|
| 87. |
2019
Flore Gouel,Anne-Sophie Rolland,Jean-Christophe Devedjian,Thierry Burnouf,David Devos.
Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates.
. Frontiers in Neurology
.2019
|
|
| 88. |
2019
Jean‐Claude Faber, Jay Epstein,Thierry Burnouf.
Improving haemophilia therapy in developing countries: virus-safe cryoprecipitate.
. Vox Sanguinis
.2019
|
|
| 89. |
2019
Burnouf T,Chen CH,Tan SJ,Tseng CL,Lu KY,Chang LH, Nyambat B, Huang SC, Jheng PR, Aditya RN, Mi FL, Chuang ER.
A bioinspired hyperthermic macrophage-based polypyrrole-polyethylenimine (Ppy-PEI) nanocomplex carrier to prevent and disrupt thrombotic fibrin clots.
. Acta Biomaterialia
.2019
;(96):468-479
|
|
| 90. |
2019
Burnouf T.
Blood products: unmet needs for essential blood products
. Lancet Haematology
.2019
|
|
| 91. |
2019
Gao Y,Ku N-J,Sunb T-C,Higuchi A,Hung C-S,Lee H H-C, Ling Q-D, Cheng N-C, Umezawa A, Barro L, Burnouf T, Ye Q, Chen H..
Effect of human platelet lysate on the differentiation ability of human adipose-derived stem cells cultured on ECM-coated surfaces.
. Journal of Materials Chemistry C
.2019
|
|
| 92. |
2019
Burnouf T,Agrahari V,Agrahari V.
Extracellular vesicles as nanomedicines: hopes and hurdles in clinical translation.
. The International Journal of Nanomedicine
.2019
|
|
| 93. |
2019
Burnouf T,Barro L,Nebie O,Wu Y-W,Goubran H,Knutson F, Segatchian J.
Virus safety of human platelet lysate for cell therapy and regenerative medicine: moving forward yes, but without forgetting the past.
. Transfusion and Apheresis Science
.2019
|
|
| 94. |
2019
Burnouf T,Epstein J,Faber J-C.
Recovered plasma: Call for quality standards to end wastage.
. Vox Sanguinis
.2019
|
|
| 95. |
2019
Nebie O,Devos D,Vingtdeux V,Barro L,Devedjian JC,Jonneaux A, Chou ML, Bordet R, Buée L, Knutson F, Blum D, Burnouf T.
The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates.
. Journal of Biomedical Science
.2019
;(26)
|
|
| 96. |
2019
Thierry Burnouf.
Blood products: unmet needs for essential medicines
. Lancet Haematol
.2019
|
|
| 97. |
2018
Mantosh Kumar Satapathy,Batzaya Nyambat,Chih-Wei Chiang, Chih-Hwa Chen,Pei-Chun Wong,Po-Hsien Ho.
A gelatin hydrogel-containing nano-organic PEI–Ppy with a photothermal responsive effect for tissue engineering applications
. Molecules
.2018
|
|
| 98. |
2018
Renn TY,Huang YK,Feng SW,Wang HW,Lee WF,Lin CT, Burnouf T, Chen LY, Kao PF, Chang HM.
Prophylactic supplement with melatonin successfully suppresses the pathogenesis of periodontitis through normalizing RANKL/OPG ratio and depressing the TLR4/MyD88 signaling pathway
. Journal of Pineal Research
.2018
;(64):1-21
|
|
| 99. |
2018
Victor J. Drew,Ching-Li Tseng,Jerard Seghatchian,Thierry Burnouf.
Reflections on dry eye syndrome treatment: Therapeutic role of blood products
. Frontiers in Medicine
.2018
|
|
| 100. |
2018
Sut C,Hamzet-Cognasse H,Arthaud CA,Evraud MA,Chettab K,Dumontet C, Laradi S, Burnouf T, Garraud O, Cognasse F.
Platelet concentrate supernatants alter endothelial cell mRNA and protein expression patterns as a function of storage length
. Transfusion
.2018
|
|
| 101. |
2018
Barro L,Drew V,Poda GD,Tagny CT,El-Ekiaby M,Owusu-Ofori S, Burnouf T.
Blood transfusion in sub-Saharan Africa: filling the gap to fulfill local needs and respond to present and future challenges
. Vox Sanguinis (in press)
.2018
|
|
| 102. |
2018
Huang CN,Tang ZT,Chan FE,Burnouf T,Huang WC,Chen PC.
Fabrication of co-electrodeposition of plasma proteins/iridium oxide hybrid films
. Ceramics International
.2018
;(44):S117-S120
|
|
| 103. |
2018
Thierry Burnouf.
Principles of haemophilia care: The Asia- Pacific perspective
. Haemophilia
.2018
|
|
| 104. |
2018
Paul Harrison,J. Alsousou, Liverpool, UK; I. Andia, Barakaldo, Spain; T. Burnouf, Taipei City, Taiwan; D. Dohan Ehrenfest, Gwangju, South Korea; P. Everts, Fort Myers, USA; H. Langer, Tu€bingen, Germany; J. Magalon, Marseille, France; R. Marck, Amsterdam, the Netherlands; P. Gre- sele, Perugia, Italy..
The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH
. Journal of Thrombosis and Haemostasis
.2018
;(16):1895-1900
|
|
| 105. |
2018
Thierry Burnouf.
What can be learned in the snake antivenom field from the developments in human plasma derived products?
. Toxicon
.2018
;(146):77-86
|
|
| 106. |
2018
D. Strunk,M. Lozano,D. C. Marks,Y. S. Loh,G. Gstraunthaler,H. Schennach, E. Rohde, S. Laner-Plamberger, M. Oller, J. Nystedt, R. Lotfi, M. Rojewski, H. Schrezenmeier, K. Bieback, R. Schafer, T. Bakchoul, M. Waidmann, S. M. Jonsdottir-Buch, H. Montazeri, O. E. Sigurjonsson, P. Iudicone, D. Fioravanti, L. Pierelli, M. Introna, C. Capelli, A. Falanga, M. Takanashi, O. Lopez-Villar, T. Burnouf, J. A. Reems, J. Pierce, A. M. Preslar, K. Schallmoser.
International Forum on GMP-grade human platelet lysate for cell propagation
. Vox Sanguinis
.2018
;(113)
|
|
| 107. |
2018
Lassina Barro,Victor J. Drew,Ghislain G. Poda,Claude T. Tagny,Magdy El-Ekiaby,Shirley Owusu-Ofori, Thierry Burnouf.
Blood transfusion in sub-Saharan Africa: understanding the missing gap and responding to present and future challenges
. Vox Sanguinis
.2018
;(113):726-736
|
|
| 108. |
2018
Jean-Claude Faber,Thierry Burnouf.
Bitter progress in the treatment of haemophilia A in low-income countries
. Lancet Haematology
.2018
;(5)
|
|
| 109. |
2018
Thierry Burnouf,Pierre-Alain Burnouf,Yu-Wen Wu,Er-Yuan Chuang,Long-Sheng Lu,Hadi Goubran.
Circulatory-cell-mediated nanotherapeutic approaches in disease targeting
. Drug Discovery Today
.2018
;(23):934-943
|
|
| 110. |
2018
D. Strunk,M. Lozano,D. C. Marks,Y. S. Loh,G. Gstraunthaler,H. Schennach, E. Rohde, S. Laner-Plamberger, M. Oller, J. Nystedt, R. Lotfi, M. Rojewski, H. Schrezenmeier, K. Bieback, R. Schafer, T. Bakchoul, M. Waidmann, S. M. JonsdottirBuch, H. Montazeri, O. E. Sigurjonsson, P. Iudicone, D. Fioravanti, L. Pierelli, M. Introna, C. Capelli, A. Falanga, M. Takanashi, O. Lόpez-Villar, T. Burnouf, J. A. Reems, J. Pierce, A. M. Preslar, K. Schallmoser.
International Forum on GMP‐grade human platelet lysate for cell propagation: summary
. Vox Sanguinis
.2018
;(113):80-87
|
|
| 111. |
2018
Thierry Burnouf.
Multifaceted regenerative lives of‘expired’platelets
. Vox Sanguinis
.2018
;(13):323-330
|
|
| 112. |
2018
Thierry Burnouf.
Preface: Annals of Blood Special issue on plasma fractionation.
. Annals of Blood
.2018
|
|
| 113. |
2018
Thierry Burnouf,Magdy El Ekiaby,Hadi Goubran,Mirjana Radosevich,Ahmed El Ekiaby.
Role of the mini-pool cryoprecipitate technology for cost-saving and guarantee of local Factor VIII, Von Willebrand Factor and Fibrinogen product supply: Egypt experience.
. Annals of Blood
.2018
|
|
| 114. |
2018
Thierry Burnouf.
An overview of plasma fractionation
. Annals of Blood
.2018
|
|
| 115. |
2017
Kim MJ,Burnouf T.
The Current Global Status and Production Trends of Plasma Fractionation
. Korean J Blood Transfus
.2017
|
|
| 116. |
2017
Gouel F,Do Van B,Chou ML,Jonneaux A,Moreau C,Bordet R, Burnouf T, Devedjian JC, Devos D.
The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways.
. J Tissue Eng Regen Med
.2017
;(11):3236-3240
|
|
| 117. |
2017
Wang TJ,Chen MS,Chou ML,Lin HC,Seghatchian J,Burnouf, T.
Comparison of three human platelet lysates used as supplements for in vitro expansion of corneal endothelium cells
. Transfus Apher Sci
.2017
;(56):769-773
|
|
| 118. |
2017
Goubran H,Seghatchian J,Prokopchuk-Gauk O,Radosevic J,Sabry W,Iqbal N, Burnouf T.
Reflections on multiple strategies to reduce transfusion in cancer patients: A joint narrative.
. Transfus Apher Sci
.2017
;(56)
|
|
| 119. |
2017
Strunk D,Lozano, M,Marks, DC,Loh YS,Gstraunthaler G,Schennach H, Rohde E, Laner-Plamberger S, Oller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schafer R, Bakchoul T Waidmann M, Jonsdottir-Buch SM, Montazeri, H, Sigurjonsson OE, Iudicone, P, Fioravanti, D, Pierelli, L, Introna, M, Capelli, C, Falanga, A, Takanashi, M, Lόpez-Villar O, Burnouf T, Reems, JA, Pierce, J, Preslar, AM, Schallmoser, K.
International Forum on GMP-grade human platelet lysate for cell propagation: a summary
. Vox Sanguinis
.2017
|
|
| 120. |
2017
Goubran H,Seghatchian J,Radosevic J,Ragab G,Burnouf T.
The microbiome and transfusion in cancer patients
. Transfus Apher Sci
.2017
;(56):330-335
|
|
| 121. |
2017
Goubran H,Sheridan D,Radosevic J,Burnouf T,Seghatchian J.
Transfusion-related immunomodulation and cancer
. Transfus Apher Sci
.2017
;(56):336-340
|
|
| 122. |
2017
Burnouf T,Elemary M,Radosevic J,Seghatchian J,Goubran H.
Platelet transfusion in thrombocytopenic cancer patients: Sometimes justified but likely insidious
. Transfus Apher Sci
.2017
;(56):305-309
|
|
| 123. |
2017
Iqbal N,Haider K,Sundaram V,Radosevic J,Burnouf T,Seghatchian J, Goubran H.
Red blood cell transfusion and outcome in cancer
. Transfus Apher Sci
.2017
;(56):287-290
|
|
| 124. |
2017
Drew V,Barro L,Seghatchian J,Burnouf T.
Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prosoects for developing countries
. Blood Transfusion (Italy)
.2017
;(15):1-11
|
|
| 125. |
2017
Sut C,Tariket S,Chou ML,Garraud O,Laradi S,Hamzeh-Cognasse H, Seghatchian J, Burnouf T, Cognasse F.
Duration of red blood cell storage and inflammatory marker generation.
. Blood Transfus
.2017
;(15):145-152
|
|
| 126. |
2017
Burnouf T,Dye JM,Abayomi A.
Convalescent Plasma and the Dose of Ebola Virus Antibodies
. New England Journal of Medicine
.2017
;(376):1296-1297
|
|
| 127. |
2017
Lee KT,Lu YJ,Mi FL,Burnouf T,Wei YT,Chiu Shao-Chieh, Chaung EY, Lu SY.
Catalase-Modulated Heterogeneous Fenton Reaction for Selective Cancer Cell Eradication: SnFe2O4 Nanocrystals as an Effective Reagent for Treating Lung Cancer Cells
. ACS Appl. Mater. & Interfaces
.2017
|
|
| 128. |
2017
Chou ML,Wu JW,Gouel F,Jonneaux A,Timmerman K,Renn TY, Laloux C, Chang HM, Lin LT, Devedjian JC, Devos D, Burnouf T.
Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease
. Biomaterials
.2017
;(142):77-89
|
|
| 129. |
2017
Mi FL,Burnouf T*,Lu SY,Lu YJ,Lu KY,Ho YC, Kuo CY, Chuang EY.
Self-Targeting, Immune Transparent Plasma Protein Coated Nanocomplex for Noninvasive Photothermal Anticancer Therapy.
. Adv Healthcare Mat
.2017
;(6):1700181-1700181
|
|
| 130. |
2016
Burnouf T.
Plasma for fractionation: looking at its safety from a comprehensive angle.
. Transfusion
.2016
;(56):2900-2901
|
|
| 131. |
2016
Seghatchian J,Espinosa A,Burnouf T.
Commentary on technical specifications and safety requirements of serum eye drops: Keeping a close eye on the content in cytokines.
. Transfusion & Apheresis Science
.2016
|
|
| 132. |
2016
Seghatchian J,Espinosa A,Burnouf T.
Quality, safety, and sustained therapeutic efficacy of blood-derived serum eye drops to treat dry eye syndrome: R&D road map for future progress.
. Transfusion & Apheresis Science
.2016
|
|
| 133. |
2016
T. Burnouf,J. M. Dye,J. Ambe,A. Abayomi.
Convalescent Ebola plasma: assessing neutralizing antibodies at the right stage
. Vox Sanguinis
.2016
|
|
| 134. |
2016
T. Burnouf.
Current status and new developments in the production of plasma derivatives
. vox sanguinis
.2016
;(11):18-25
|
|
| 135. |
2016
Thierry Burnouf, Ph.,Brian Conton,John M. Dye, Ph.D..
Convalescent Plasma for Ebola Virus Disease
. New England Journal of Medicine
.2016
;(374):2499
|
|
| 136. |
2016
Chueh-Yao Chung,Ching-Hsuan Liu,Thierry Burnouf,Guey-Horng Wang,Shun-Pang Chang,Alagie Jassey, Chen-Jei Tai, Cheng-Jeng Tai, Ching-Jang Huang,Christopher D. Richardson, Ming-Hong.
Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry
. Antiviral Research
.2016
|
|
| 137. |
2016
Yu-Wen Wu,Hadi Goubran,Jerard Seghatchian,Thierry Burnouf.
Smart blood cells and microvesicle-based Trojan Horse drug delivery: Merging blood transfusion and biomedical engineering expertise in the field of nanomedicine
. Transfusion and Apheresis Science
.2016
|
|
| 138. |
2016
Hadi A. Goubran,Mohamed Elemary,Miryana Radosevich,Jerard Seghatchian,Magdy El-Ekiaby,Thierry Burnouf.
Impact of Transfusion on Cancer Growth and Outcome
. Cancer Growth and Metastasis
.2016
|
|
| 139. |
2016
Ching-Li Tseng,Zhi-Yu Chen,Ting-Yi Renn,Shun-Hung Hsiao,Thierry Burnouf.
Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome
. PLoS One
.2016
|
|
| 140. |
2016
T . BURNOUF,P.F.W. STRENGERS.
Risks of inhibitors from recombinant factor VIII: a quarter of a century to reach the conclusion
. Journal of Thrombosis and Haemostasis
.2016
;(14):2073-2074
|
|
| 141. |
2016
Jerard Seghatchian,Aurora Espinosa,Thierry Burnouf.
Quality, safety and sustained therapeutic efficacy of blood derived serum eye drops to treat dry eye syndrome: R&D road map for future progress
. Transfusion and Apheresis Science
.2016
|
|
| 142. |
2016
Yao-Ting Hsieh,Lori Mullin,Patricia Greenhalgh,Michael Cunningham,Elizabeth Goodrich,Jessica Shea,Eric Youssef, Thierry Burnouf.
Single-use technology for solvent/detergent virus inactivation of industrial plasma products
. TRANSFUSION
.2016
|
|
| 143. |
2016
Ying-Jan Weng,Anne Husebekk,Björn Skogen,Mette Kjaer,Liang-Tzung Lin,Thierry Burnouf.
Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
. PLOS ONE
.2016
|
|
| 144. |
2016
Kao YC,Bailey A,Samminger B,Tanimoto J,Burnouf T.
Removal process of prion and parvovirus from human platelet lysates used as clinical-grade supplement for ex vivo cell expansion
. Cytotherapy
.2016
;(18):911-924
|
|
| 145. |
2016
Burnouf T,Strunk D,Koh M,Schallmoser K.
Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
. Biomaterials
.2016
;(76):371-387
|
|
| 146. |
2016
Chou ML,Burnouf T.
Current methods to manufacture human platelet lysates (HPLs) for cell therapy and tissue engineering; possible trends in product safety and standardisation
. Vox Sanguinis
.2016
;(12):168-175
|
|
| 147. |
2016
Thierry Burnouf,Brian Conton,John M. Dye.
To the editor
. New England Journal of Medicine
.2016
|
|
| 148. |
2016
Ming Li Chou,Thierry Burnouf.
Current methods to manufacture human platelet lysates (HPLs) for cell therapy and tissue engineering: possible trends in product safety and standardization
. Vox Sanguinis
.2016
;(12):168-175
|
|
| 149. |
2016
M.L. Chou, T. Burnouf.
Current methods to manufacture human platelet lysates (HPLs) for cell therapy and tissue engineering; possible trends in product safety and standardisation.
. Vox Sanguinis
.2016
|
|
| 150. |
2015
Hadi Goubran,Waleed Sabry,Rami Kotb,Jerard Seghatchian,Thierry Burnouf.
Platelet microparticles and cancer: An intimate cross-talk
. Transfusion and Apheresis Science
.2015
|
|
| 151. |
2015
Shih DTB,Burnouf T.
Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion
. New Biotechnology
.2015
;(32):199-211
|
|
| 152. |
2015
Lin HC,Chang HW,Hsiao SH,Chou ML,Seghatchian J,Burnouf T.
Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro.
. Transfus Apher Sci.
.2015
|
|
| 153. |
2015
Burnouf T,Chou ML,Goubran H,Cognasse F,Garraud O,Seghatchian J.
An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful?
. Transfusion and Apheresis Science
.2015
;(53):137-145
|
|
| 154. |
2015
Cognasse F,Hamzeh-Cognasse H,Laradi S,Chou ML,Seghatchian J,Burnouf T, Boulanger C, Garraud O, Amabile N..
The role of microparticles in inflammation and transfusion: A concise review.
. Transfus Apher Sci.
.2015
;(53):159-167
|
|
| 155. |
2015
El-Ekiaby M,Vargas M,Sayed M,Gorgy G,Goubran H,Radosevic M, Burnouf T.
Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries.
. PLoS Negl Trop Dis.
.2015
|
|
| 156. |
2015
Chou ML,Burnouf T,Chang SP,Hung TC,Lin CC,Richardson CD, Lin LT.
TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.
. PLOS ONE
.2015
|
|
| 157. |
2015
Chou ML,Bailey A,Avory T,Tanimoto J,Burnouf T.
Removal of transmissible spongiform encephalopathy prion from large volumes of cell culture media supplemented with fetal bovine serum by using hollow fiber anion-exchange membrane chromatography.
.
.2015
;(1):1-1
|
|
| 158. |
2015
Vargas M,Segura A,Wu YW,Herrera M,CHou ML,Villalta M, LeonG, Burnouf T.
Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity.
. Vox Sanguninis
.2015
;(108):169-177
|
|
| 159. |
2015
Goubran HA,Burnouf T,Stawik J,Segatchian J.
Platelet microparticle: A sensitive physiological “fine tuning” balancing factor in health and disease
. Transfusion & Apheresis Science
.2015
;(52):12-18
|
|
| 160. |
2015
T.-Y. Renn,Y.-H. Kao,C._C. Wang,T. Burnouf.
Anti-inflammatory effects of platelet biomaterials in a macrophage cellular model
. Vox Sangunis
.2015
;(109):138-147
|
|
| 161. |
2015
Chou ML,Lin LT,Devos D,Burnouf T.
Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro assessment.
. Transfusion
.2015
;(55):2433-2444
|
|
| 162. |
2015
Tseng CL,Seghatchain J,Burnouf T.
Animal models to assess the therapeutic efficacy of human serum and serum-converted platelet lysates for dry eye syndrome: Seeing is believing.
. Transfusion & Apheresis Science
.2015
;(53):95-98
|
|
| 163. |
2015
Hsiu-Chen Lin,Hui-Wen Chang,Shun-Hung Hsiao,Ming-Li Chou,Jeard Seghatchian,Thierry Burnouf.
Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro
. Transfusion & Apheresis Science
.2015
|
|
| 164. |
2015
Guttierez J,Burnouf T,Harrison RA,Calvete JJ,Brown N,Jensen SD, Warrell DA, Williams DJ.
A Call for Incorporating Social Research in the Global Struggle against Snakebite.
. PLOS Neglected Tropical Diseases
.2015
|
|
| 165. |
2014
Sherif N,Goubran HA,Hassan A,Burnouf T*,,El-Ekiaby M.
An approach to outreach patients with Von Willebrand Disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
. Haemophilia
.2014
;(20):238-243
|
|
| 166. |
2014
Wu YW,Champagne J,Toueille M,Gantier R,Burnouf, T.
Dedicated removal of immunoglobulin (Ig)A, IgM, and Factor (F)XI/activated FXI from human plasma IgG.
. Transfusion
.2014
|
|
| 167. |
2014
Gutierrez JM,Burnouf T,Harrison RA,Calvete JJ,Kuch U,Warrell DA,William DJ.
A multi-component strategy to improve the availability of effective and safe antivenom immunoglobulins for treating snakebite envenoming.
. Bulletin of the World Health Organization
.2014
;(0):0-0
|
|
| 168. |
2014
Burnouf T,Seghatchian J,Goubran HA.
Multifaceted regenerative lives of expired platelets in the second decade of the 21st century.
. Transfusion & Apheresis Science.
.2014
|
|
| 169. |
2014
Germishuizen WA,Gyure DC,Stubbings D,Burnouf T*.
Quantifying the thrombogenic potential of human plasma-derived immunoglobulin products
. Biologicals
.2014
|
|
| 170. |
2014
Burnouf T,Goubran HA,Chou ML,Devos, D,Radosevic M..
Platelet microparticles: detection and assessment of their paradoxical functional roles in disease and regenerative medicine.
. Blood Rev
.2014
;(4):155-66
|
|
| 171. |
2014
Goubran HA,Stakiw J,Radosevich M,Burnouf T.
Platelets effects on tumor growth
. Seminars in Oncology
.2014
;(41):359-69
|
|
| 172. |
2014
Goubran HA*,Kotb R,Stakiw J,Emara M,Burnouf T.
Regulation of tumor growth and metastasis: the role of tumor microenvironment.
. Cancer Growth Metastasis.
.2014
;(7):9-18
|
|
| 173. |
2014
Goubran HA,Stakiw J,Radosevich M,Burnouf T.
Platelet-cancer interactions.
. Seminars in Thrombosis and Hemostasis
.2014
;(40):296-305
|
|
| 174. |
2014
Burnouf T,Emmanuel J,Mbanya D,El-Ekiaby M,Murphy W,Field S.
Ebola: a call for blood transfusion strategy in sub-Saharan Africa
. Lancet
.2014
;(384):1347-1348
|
|
| 175. |
2014
Chou ML,Burnouf T,Wang TJ.
Ex vivo Expansion of Bovine Corneal Endothelial Cells in Xeno-Free Medium Supplemented with Platelet Releasate
. PLOS ONE
.2014
;(9)
|
|
| 176. |
2014
Thierry Burnouf a,Jerard Seghatchian.
“Go no Go” in plasma fractionation in the world’s emerging economies: Still a question asked 70 years after the COHN process was developed!
. Transfusion and Apheresis Science
.2014
;(51):113-119
|
|
| 177. |
2014
Thierry Burnouf,Jerard Seghatchian.
Ebola virus convalescent blood products: Where we are now and where we may need to go
. Transfusion and Apheresis Science
.2014
;(51):120-125
|
|
| 178. |
2014
Thierry Burnouf,Hadi Alphonse Goubr,Jerard Seghatchian.
Multifaceted regenerative lives of expired platelets in the second decade of the 21st century
. Transfusion and Apheresis Science
.2014
;(51):107-112
|
|
| 179. |
2014
Thierry Burnouf.
New approaches for manufacturing plasma derivatives.
. ISBT Science Series
.2014
|
|
| 180. |
2013
Burnouf T,Goubran H,Chen TM,Ou KL,El-Ekiaby M,Radosevic M.
Blood-derived biomaterials and platelet growth factors in regenerative medicine.
. Blood Reviews
.2013
;(2):77-89
|
|
| 181. |
2013
Lee YL,Lee LW,Su CY,Hsiao G,Yang YY,Leu SJ, Shieh YH, Burnouf T.
Virally inactivated human platelet concentrate lysate induces regulatory T cells and immunosuppressive effect in a murine asthma model
. Transfusion
.2013
;(53):1918-1928
|
|
| 182. |
2013
Goubran HA,Burnouf T,Radosevic M,El-Ekiaby M.
The platelet-cancer loop
. European Journal of Internal Medicine
.2013
;(24):393-400
|
|
| 183. |
2013
Tzeng YS,Deng SC,Wang CH,Tsai JC,Chen TM,Burnouf T.
Treatment of nonhealing diabetic lower extremity ulcers with skin graft and autologous platelet gel: a case series
. BioMed Research International
.2013
|
|
| 184. |
2013
Pai SC,Burnouf T,Chen JW,Lin LI.
Human Platelet Antigen Alleles in 998 Taiwanese Blood donors determined by sequence-specific primer polymerase chain reaction.
. BioMed Research International
.2013
|
|
| 185. |
2013
Burnouf T,Chou ML,Cheng LH,Li ZR,Wu YW,El-Ekiaby M, Tsai KH.
Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate
. Vox Sanguinis
.2013
;(104):1-6
|
|
| 186. |
2013
Chen TM,Tzeng YS,Tsai JC,Burnouf T.
Single-donor allogeneic platelet fibrin glue and osteoconductive scaffold in orbital floor fracture reconstruction
. annals of plastic surgery
.2013
;(70):370-374
|
|
| 187. |
2013
Burnouf T,Chou ML,Wu YW,Su CY,Lee LW.
Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria
. transfusion
.2013
;(53):138-146
|
|
| 188. |
2012
Vargas M,Segura A,Herrera M,Villalta M,Angulo Y,Gutiérrez JM, León G, Burnouf T.
Purification of IgG and albumin from human plasma by aqueous two phase system fractionation
. Biotechnol. Prog
.2012
;(28):1005-1011
|
|
| 189. |
2012
Solano S,Segura Á,León G,Gutiérrez JM,Burnouf T.
Low pH formulation of whole IgG antivenom: Impact on quality, safety, neutralizing potency and viral inactivation
. Biologicals
.2012
;(40):129-133
|
|
| 190. |
2012
H.A. Goubran,T. Burnouf.
Platelets, coagulation and cancer: Multifaceted Interactions
. American Medical Journal
.2012
;(3):130-140
|
|
| 191. |
2012
Burnouf T,Kuo YP,Blum D,Burnouf S,Su CY.
Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor
. TRANSFUSION
.2012
;(52):1721-1728
|
|
| 192. |
2012
Burnouf T,Lee CY,Luo CW,Kuo YP,Chou ML,Wu YW, Tseng YH, Su CY.
Human blood-derived fibrin releasates: Composition and use for the culture
. Biologicals
.2012
;(40):21-30
|
|
| 193. |
2012
Chou ML,Wu YW,Su CY,Lee LW,Burnouf T.
Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria
. Vox Sanguinis
.2012
;(102):277-284
|
|
| 194. |
2011
Burnouf T.
Recombinant plasma proteins
. Vox Sanguinis
.2011
;(100):68-83
|
|
| 195. |
2011
Shih DT,Chen JC,Chen WY,Kuo YP,Su CY,Burnouf T.
Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally-inactivated allogeneic human platelet lysate.
. transfusion
.2011
;(51):770-778
|
|
| 196. |
2011
Gutiérrez JM,León G,Burnouf T.
Antivenoms for the treatment of snakebite envenomings: The road ahead
. Biologicals
.2011
;(39):129-142
|
|
| 197. |
2011
Burnouf T,Radosevic M,El-Ekiaby M,Goubran H.
Pathogen Reduction Technique for fresh frozen plasma,cryoprecipitate and plasma fractions minipools prepared in disposable processing bag systems
. transfusion
.2011
;(51):446-447
|
|
| 198. |
2011
El-Ekiaby M,Goubran HA,Radosevich M,Abd-Allah A,El-Ekiaby A,Burnouf T.
Pharmacokinetics study of minipool solvent/detergent-filtered cryoprecipitate factor VIII
. Haemophilia
.2011
;(17):e884-e888
|
|
| 199. |
2011
Burnouf T,Chang CW,Kuo YP,Wu YW,Tseng YH,Su CY.
A chromatographically purified human TGF-β1 fraction from virally-inactivated platelet lysates
. Vox Sanguinis
.2011
;(101):215-220
|
|
| 200. |
2010
Burnouf PA,Juan PK,Su CY,Kuo YP,Chou ML,Su CH, Tseng YH, Lin CT, Burnouf T.
A novel virally-inactivated human platelet lysate preparation rich in TGF-β, EGF and IGF, depleted of PDGF and VEGF
. Biotechnology and Applied Biochemistry
.2010
;(56):151-160
|
|
| 201. |
2010
Burnouf T,Kuo YP,Huang CT,Tseng YH,Lin CT,Su CY.
A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets
. transfusion
.2010
;(50):1702-1711
|
|
| 202. |
2010
Chen TM,Tsai JC,Burnouf T.
A Novel Technique Combining Platelet Gel, Skin Graft, and Fibrin Glue for Healing Recalcitrant Lower Extremity Ulcers
. Dermatologic surgery
.2010
;(36):453-460
|
|
| 203. |
2010
Thierry Burnouf,Allan Lihme,Marie BendixHansen,Inga VaarstAndersen.
A novel core fractionation process of human plasma by expanded bed adsorption chromatography
. Analytical Biochemistry
.2010
|
|
| 204. |
2010
Thierry Burnouf,Ya PoKuo,Yueh-LunLee,Yu HongTseng,Ching-HuaSu,Chen YaoSu.
Influence of ethanol on the release of growth factors in human blood-derived platelet gels
. Biologicals
.2010
|
|
| 205. |
2010
H. Goubran , M. El‐Ekiaby,M. Radosevich , M. A. Sayed, J. Goudemand , C. Caron,D. Blum , S. Burnouf, L. De Melo , N. El‐Sharkawy,V. Soulié , J. Adam , Thierry Burnouf.
Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system
. Transfusion Medicine
.2010
|
|
| 206. |
2009
Thierry Burnouf,M. Radosevich.
Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance.
. Vox Sanguinis
.2009
|
|
| 207. |
2009
Thierry Burnouf,ÁlvaroSegura,GuillermoLeón,Chen-YaoSu,osé-MaríaGutiérrez.
Assessment of the impact of solvent/detergent treatment on the quality and potency of a whole IgG equine antivenom
. Biologicals
.2009
|
|
| 208. |
2009
Thierry Burnouf,C.‐Y. Su, Y. P. Kuo, Y. C. Lin,C.‐T. Huang, Y. H. Tseng.
A virally inactivated functional growth factor preparation from human platelet concentrates
. Vox Sanguinis
.2009
|
|
| 209. |
2009
Thierry Burnouf,Chen YaoSu,Ya PoKuo,Yu HongTseng,Ching-HuaSu.
In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF
. Oral Surgery
.2009
|
|
| 210. |
2009
Thierry Burnouf,AlbertFarrugia,TheoEvers,Pierre-FrancoisFalcou,LuizAmorim,SylviaThomas.
Plasma fractionation issues
. Biologicals
.2009
|
|
| 211. |
2009
Thierry Burnouf,M. El‐Ekiaby, M. Radosevich,H. Goubran, M. El Sayed.
New methods of plasma fractionation – a presentation of the ‘mini‐pool’ fractionation procedure developed in Egypt
. ISBT Science Series
.2009
|
|
| 212. |
2009
T. Burnouf,C.‐Y. Su,M. Radosevich,H. Goubran,M. El‐Ekiaby.
Blood-derived biomaterials: fibrin sealant, platelet gel and platelet fibrin glue.
. ISBT Science Series
.2009
|
|
| 213. |
2009
Burnouf T,Sayed MA,Radosevich M,El-Ekiaby M.
Comparative removal of solvent and detergent viral inactivating agents from human intravenous immunoglobulin G preparations using SDR HyperD and C18 sorbents
. Analytical Biochemistry
.2009
;(389):69-73
|
|
| 214. |
2008
Burnouf T,Tseng YH,Kuo YP,Su CY.
Solvent/detergent treatment of platelet concentrates enhances the release of growth factors
. transfusion
.2008
;(48):1090-1098
|
|
| 215. |
2008
Su CY,Kuo YP,Nieh HL,Tseng YH,Burnouf T.
Quantitative assessment of the kinetics of growth factors release from platelet gel
. transfusion
.2008
;(48):2414-2420
|
|
| 216. |
2008
Thierry Burnouf.
Quality of plasma and its fractionation.
. ISBT Science Series
.2008
|
|
| 217. |
2008
Thierry Burnouf,H.A.Goubran,M.Radosevich,M.El-Ekiaby.
Inactivation virale par procédé solvant-détergent de minipools de plasma, de cryoprécipité et de surnageant de cryoprécipité dans des dispositifs à usage unique
. Transfusion Clinique et Biologique
.2008
|
|
| 218. |
2008
Thierry Burnouf,C. CARON,M. RADOSEVICH,H. A. GOUBRAN,J. GOUDEMAND,M. EL‐EKIABY.
Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems
. Haemophilia
.2008
|
|
| 219. |
2008
Thierry Burnouf.
Actualités sur les médicaments dérivés du sang
. Hematologie
.2008
|
|
| 220. |
2008
Thierry Burnouf,Tim Mo Chen,Jui-Che Tsai.
Cranioplasty Using Osteoconductive Scaffold and Platelet Glue
. The Journal of Trauma: Injury, Infection, and Critical Care.
.2008
|
|
| 221. |
2007
Thierry Burnouf, H. A. Goubran, M. Radosevich, M. El‐Ekiaby.
Preparation and viral inactivation of cryoprecipitate in blood banks in resource-limited countries
. ISBT Science Series
.2007
|
|
| 222. |
2007
Thierry Burnouf,FokkeTerpstra,GeorgeHabib,SalwaSeddik.
Assessment of viral inactivation during pH 3.3 pepsin digestion and caprylic acid treatment of antivenoms
. Biologicals
.2007
|
|
| 223. |
2007
Thierry Burnouf,Hadi AlphonseGoubran,MiryanaRadosevich,Makram A.Sayed,GeorgeGorgy,MagdyEl-Ekiaby.
Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma
. Biologicals
.2007
|
|
| 224. |
2007
Thierry Burnouf.
Modern Plasma Fractionation
. Transfusion Medicine Reviews
.2007
|
|
| 225. |
2007
José MaríaGutiérrez,HisakoGondo Higashi,FanHui Wen,Thierry Burnouf.
Strengthening antivenom production in Central and South American public laboratories: Report of a workshop
. Toxicon
.2007
|
|
| 226. |
2007
Miryana Radosevich, Thierry Burnouf.
Biological and biochemical assays to ensure the quality and safety of plasma-derived products: Factor VIII concentrates
. Current Pharmaceutical Analysis
.2007
|
|
| 227. |
2005
T. Burnouf,M. Radosevich,H. A. Goubran,H. Willkommen.
Place of nanofiltration for assuring viral safety of biologicals.
. Current Nanoscience
.2005
|
|